10 Papers
21 Citations
Aida Vega is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 6 publications.
Chat about Author
Papers
Barriers and facilitators affecting the implementation of substance use screening in primary care clinics: a qualitative study of patients, providers, and staff
Jennifer McNeely,Pritika C. Kumar,Traci Rieckmann,Erica Sedlander,Sarah Farkas,Christine Chollak,Joseph L. Kannry,Aida Vega,Eva Waite,Lauren Peccoralo,Richard N. Rosenthal,Dennis McCarty,John Rotrosen +12 more
TL;DR: It is suggested that screening programs should clearly communicate the goals of screening to patients and proactively counteract stigma, address staff concerns regarding time and workflow, and provide education as well as treatment resources to primary care providers.
Comparison of Methods for Alcohol and Drug Screening in Primary Care Clinics.
Jennifer McNeely,Angéline Adam,John Rotrosen,Sarah E. Wakeman,Timothy E. Wilens,Joseph L. Kannry,Richard N. Rosenthal,Aimee Wahle,Seth Pitts,Sarah Farkas,Carmen Rosa,Lauren Peccoralo,Eva Waite,Aida Vega,Jennifer Kent,Catherine K. Craven,Tamar A. Kaminski,Elizabeth S. Firmin,Benjamin M. Isenberg,Melanie Harris,Andre Kushniruk,Leah Hamilton +21 more
- 03 May 2021
TL;DR: In this article, the authors evaluated how to best implement electronic health record (EHR)-integrated screening for substance use by comparing commonly used screening methods and examining their association with implementation outcomes.
Institutional profile: translational pharmacogenomics at the Icahn School of Medicine at Mount Sinai.
Stuart A. Scott,Stuart A. Scott,Aniwaa Owusu Obeng,Aniwaa Owusu Obeng,Mariana R. Botton,Mariana R. Botton,Yao Yang,Yao Yang,Erick R. Scott,Erick R. Scott,Stephen B. Ellis,Richard Wallsten,Tom Kaszemacher,Xiang Zhou,Xiang Zhou,Rong Chen,Rong Chen,Paola Nicoletti,Paola Nicoletti,Hetanshi Naik,Eimear E. Kenny,Aida Vega,Eva Waite,George A. Diaz,George A. Diaz,Joel T. Dudley,Jonathan L. Halperin,Lisa Edelmann,Lisa Edelmann,Andrew Kasarskis,Jean-Sébastien Hulot,Jean-Sébastien Hulot,Inga Peter,Erwin P. Bottinger,Kurt Hirschhorn,Pamela Sklar,Judy H. Cho,Robert J. Desnick,Robert J. Desnick,Eric E. Schadt,Eric E. Schadt +40 more
TL;DR: This overview summarizes the current state of translational pharmacogenomics at Mount Sinai, including a future outlook on the forthcoming expansions in overall support, research and clinical programs, genomic technology infrastructure and the participating faculty.
23
Implementing Algorithm-Guided Warfarin Dosing in an Ethnically Diverse Patient Population Using Electronic Health Records and Preemptive CYP2C9 and VKORC1 Genetic Testing.
A. Owusu Obeng,A. Owusu Obeng,Tom Kaszemacher,Noura S. Abul-Husn,Omri Gottesman,Aida Vega,Eva Waite,Kristin Myers,Judy H. Cho,Erwin P. Bottinger,Steve Ellis,Stuart A. Scott +11 more
TL;DR: A strategy that accounts for the complexity of race and leverages electronic health records for algorithm variables and deploying point‐of‐care dose recommendations is developed to facilitate multiethnic algorithm‐guided warfarin dosing using preemptive genetic testing.
A Real-World Precision Medicine Program Including the KidneyIntelX Test Effectively Changes Management Decisions and Outcomes for Patients With Early-Stage Diabetic Kidney Disease
Joji Tokita,David Lam,Aida Vega,Stephanie Wang,Leonard Amoruso,Tamara Muller,Nidhi Naik,S. Rathi,Sharlene Martin,Azadeh Zabetian,Catherine Liu,Catherine Sinfield,Tony McNicholas,Fergus Fleming,Steven G Coca,Girish N Nadkarni,Roger Tun,Mike Kattan,Michael Donovan,Arshad K Rahim +19 more
TL;DR: Deployment and risk stratification by KidneyIntelX was associated with an escalation in action taken to optimize cardio-kidney-metabolic health including medications and specialist referrals to optimize cardio-kidney-metabolic health.
2